Recombinant IL20 (Fletikumab Biosimilar) antibody

Catalog No. ABIN7597696

The Human Monoclonal anti-IL20 (Fletikumab Biosimilar) antibody has been validated for . It is suitable to detect IL20 (Fletikumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL20 (Fletikumab Biosimilar) antibody (ABIN7597696)

Target: IL20 (Fletikumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL20 (Fletikumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL20 (Fletikumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Fletikumab Biosimilar Antibody

Specificity: IL20, Cytokine Zcyto10, ZCYTO10, IL-20, Interleukin-20

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL20 (Fletikumab Biosimilar)

Target: IL20 (Fletikumab Biosimilar)

Alternative Name: Fletikumab Biosimilar

Target Type: Biosimilar

Background: IL20, Cytokine Zcyto10, ZCYTO10, IL-20, Interleukin-20

UniProt: Q9NYY1

CAS-No: 1357158-22-5